Top Industry Lists Archives - HSandM Magazine

Menu

Menu

Latest stories

7 Shares

TOP 100 HEALTHCARE COMPANIES

5 Shares

TOP 50 PHARMA COMPANIES

8 Shares

TOP 50 MEDICAL DEVICE COMPANIES

1 Shares

TOP 50 BIOTECH COMPANIES

More stories

in Top Industry Lists

TOP 100 HEALTHCARE COMPANIES

by hsandm November 1, 2019, 12:00 pm
in Top Industry Lists

MEDICAL DEVICE TOP 50

by hsandm July 1, 2019, 12:00 am
in Top Industry Lists

TOP 100 HEALTHCARE COMPANIES

by hsandm January 1, 2019, 12:00 pm
in Top Industry Lists

MEDICAL DEVICE TOP 50

by hsandm October 1, 2018, 12:00 pm
in Top Industry Lists

HS&M TOP LISTS

by hsandm October 1, 2018, 12:00 pm
in Top Industry Lists

REVENUES CONTINUE TO RISE: THE TOP 50 PHARMA COMPANIES

by hsandm August 1, 2018, 12:00 pm
in Top Industry Lists

BIOTECH IPOS DOUBLE, REVENUES UP 9%: THE TOP 50

by hsandm May 1, 2018, 12:00 pm
in Top Industry Lists

HS&M TOP LISTS

by hsandm December 1, 2017, 12:00 pm
in Top Industry Lists

TOP 100 HEALTHCARE COMPANIES

by hsandm October 1, 2017, 12:00 pm
in Top Industry Lists

Revenue on the Rise:The Top 50 Pharma Companies

by hsandm August 1, 2017, 12:00 pm
in Top Industry Lists

BIOTECH IPOS UP, MARKET DOWN, REVENUES FLAT: THE TOP 50

by hsandm April 1, 2017, 12:00 pm
in Top Industry Lists

TOP LISTS the publication for healthcare sales & marketing leaders ™

by hsandm April 1, 2017, 12:00 pm

Congratulations. You've reached the end of the internet.

Trending Now

183 Views0 Comments
in Headlines

Turnstone Biologics Acquires Novel Cell Therapy Platform

New York, January 20 2021 (BUSINESS WIRE) — Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of cancer immunotherapies, today announced that it has acquired California-based Myst Therapeutics, a privately held biotechnology company focused on advancing novel T-cell therapies for solid tumors. The acquisition adds a pipeline of innovative TIL programs to Turnstone’s portfolio of oncolytic virus candidates. Financial terms were not disclosed. More

by hsandm January 20, 2021, 6:14 pm

Read More
380 Views0 Comments
in Headlines

DJO® Acquires Trilliant Surgical

Dallas, TX , January 19 2021 (BUSINESS WIRE)–DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical®, a national provider of foot and ankle orthopedic implants. The acquisition of Trilliant Surgical’s leading product technologies and clinical efficacy supports DJO’s focused expansion into the adjacent high-growth $1 billion US foot and ankle market. More

by hsandm January 19, 2021, 5:31 pm

Read More
281 Views0 Comments
in Headlines

Thermo Fisher Scientific to Acquire Mesa Biotech for $450 Million

Waltham, MA , January 19 2021 (prnewswire) — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the transaction. More

by hsandm January 19, 2021, 5:02 pm

Read More
477 Views0 Comments
in Headlines

HealthTronics Names Bill Linder New Chief Executive Officer

Austin, TX, January 13, 2021 (PRNewswire) — HealthTronics, an Austin-based provider of integrated, mobilized medical technologies and services, has named Bill Linder its new Chief Executive Officer. More

by hsandm January 13, 2021, 5:49 pm

Read More
675 Views0 Comments
in Headlines

STERIS to Buy Cantel for $4.6B

Little Falls, NJ and Dublin, Ireland, January 12 2021 (Gobenewswire) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) and Cantel Medical Corp (NYSE:CMD) (“Cantel”) today announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers. More

by hsandm January 12, 2021, 5:25 pm

Read More
1.2k Views0 Comments
in Headlines

Backed by Bayer, Senti Biosciences Snags $105 Million in Series B Fundraising

Leverkusen, Germany & South San Francisco, CA, January 6 2021 (Business Wire) — Leaps by Bayer and Senti Biosciences, Inc., a leading gene circuit company, today announced a USD 105 million Series B financing round. The financing was led by Leaps by Bayer, the impact investment arm of Bayer AG. Additional investors included Matrix Partners China, Mirae Asset Capital, Ridgeback Capital and Intel Capital as well as existing investors, including New Enterprise Associates (NEA), 8VC, Amgen Ventures and Lux Capital. More

by hsandm January 6, 2021, 10:15 pm

Read More

Back to Top